Roumell Asset Management, LLC Bio Cardia, Inc. Transaction History

Roumell Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$17.7 - $32.55 $9.5 Million - $17.5 Million	-536,497 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$21.3 - $39.0 $8.56 Million - $15.7 Million	-401,883 Reduced 42.83%	536,497 $1.11 Million
Q3 2021 Nov 12, 2021	SELL	$42.6 - $58.65 $13.6 Million - $18.7 Million	-318,823 Reduced 25.36%	938,380 $2.95 Million
Q1 2021 May 14, 2021	BUY	$51.3 - $78.15 $35.5 Million - $54.1 Million	692,100 Added 122.47%	1,257,203 $5.46 Million
Q4 2020 Feb 16, 2021	BUY	$28.8 - $100.5 $6.68 Million - $23.3 Million	232,103 Added 69.7%	565,103 $1.96 Million
Q2 2020 Aug 14, 2020	BUY	$31.8 - $77.64 $10.6 Million - $25.9 Million	333,000 New	333,000 $796,000

11.2K

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $43.2M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Roumell Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Roumell Asset Management, LLC with notifications on news.